514 related articles for article (PubMed ID: 30923525)
1. Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome.
Manganelli V; Truglia S; Capozzi A; Alessandri C; Riitano G; Spinelli FR; Ceccarelli F; Mancuso S; Garofalo T; Longo A; Valesini G; Sorice M; Conti F; Misasi R
Front Immunol; 2019; 10():460. PubMed ID: 30923525
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome.
Sorice M; Buttari B; Capozzi A; Profumo E; Facchiano F; Truglia S; Recalchi S; Alessandri C; Conti F; Misasi R; Valesini G; Riganò R
Clin Exp Immunol; 2016 May; 184(2):174-82. PubMed ID: 26702877
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
4. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor over-expression in platelets of patients with anti-phospholipid syndrome: induction role of anti-β2-GPI antibodies.
Capozzi A; Manganelli V; Riitano G; Recalchi S; Truglia S; Alessandri C; Longo A; Garofalo T; Misasi R; Valesini G; Conti F; Sorice M
Clin Exp Immunol; 2019 Apr; 196(1):59-66. PubMed ID: 30549270
[TBL] [Abstract][Full Text] [Related]
6. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of high-mobility group box 1 and soluble receptor for advanced glycation end products in primary antiphospholipid antibody syndrome patients.
Tang KT; Hsieh TY; Chao YH; Lin MX; Chen YH; Chen DY; Lin CC
PLoS One; 2017; 12(5):e0178404. PubMed ID: 28558055
[TBL] [Abstract][Full Text] [Related]
8. Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I.
Ioannou Y; Zhang JY; Qi M; Gao L; Qi JC; Yu DM; Lau H; Sturgess AD; Vlachoyiannopoulos PG; Moutsopoulos HM; Rahman A; Pericleous C; Atsumi T; Koike T; Heritier S; Giannakopoulos B; Krilis SA
Arthritis Rheum; 2011 Sep; 63(9):2774-82. PubMed ID: 21618459
[TBL] [Abstract][Full Text] [Related]
9. The avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies.
Cucnik S; Kveder T; Ulcova-Gallova Z; Swadzba J; Musial J; Valesini G; Avcin T; Rozman B; Bozic B
Lupus; 2011 Oct; 20(11):1166-71. PubMed ID: 21712304
[TBL] [Abstract][Full Text] [Related]
10. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
[TBL] [Abstract][Full Text] [Related]
11. Elevated Serum Level of HMGB1 in Patients with the Antiphospholipid Syndrome.
Manganelli V; Capozzi A; Truglia S; Alessandri C; Lococo E; Garofalo T; De Carolis C; Conti F; Valesini G; Sorice M; Longo A; Misasi R
J Immunol Res; 2017; 2017():4570715. PubMed ID: 29410969
[TBL] [Abstract][Full Text] [Related]
12. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Danowski A; Kickler TS; Petri M
J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
14. β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease.
Rauch J; Salem D; Subang R; Kuwana M; Levine JS
Front Immunol; 2018; 9():2836. PubMed ID: 30619248
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
16. Altered β
Mobarrez F; Gunnarsson I; Svenungsson E
J Thromb Haemost; 2017 Sep; 15(9):1799-1806. PubMed ID: 28667788
[TBL] [Abstract][Full Text] [Related]
17. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
18. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.
Petrovas C; Vlachoyiannopoulos PG; Kordossis T; Moutsopoulos HM
J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of β₂-glycoprotein-I plasma levels in antiphospholipid syndrome (APS).
Banzato A; Pengo V
Curr Rheumatol Rep; 2014 Jun; 16(6):424. PubMed ID: 24797512
[TBL] [Abstract][Full Text] [Related]
20. Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome.
Bontadi A; Ruffatti A; Falcinelli E; Giannini S; Marturano A; Tonello M; Hoxha A; Pengo V; Punzi L; Momi S; Gresele P
Thromb Haemost; 2013 May; 109(5):901-8. PubMed ID: 23572134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
